Skip to main content
. 2019 Sep 25;2019:3057578. doi: 10.1155/2019/3057578

Table 3.

Comparison of seropositive and seronegative patients for RF and anti-CCP.

Variable RF or anti-CCP P value
Gender Seronegative Seropositive
Male 31 65 <0.05
Female 123 293 <0.05

Comorbidity Seronegative Seropositive
Diabetes 50 109 <0.05
Hypertension 51 140 <0.05
Thyroid disease 35 85 <0.05
Cancer 7 26 <0.05
Dyslipidemia 63 153 <0.05
CAD 26 69 <0.05
CKD 8 28 <0.05
Osteoporosis 14 55 <0.05
Gastro-intestinal 46 99 <0.05
Iron deficiency anemia 34 77 <0.05
Thalassemia 7 14 >0.05
Sickle cell anemia 0 2 >0.05
G6PD 6 15 >0.05
Asthma 22 37 >0.05
COPD 1 11 <0.05
Migraine 11 14 >0.05
Depression 9 18 >0.05

Erosion on X-ray Seronegative Seropositive
No 107 284 <0.05
Yes 47 74 <0.05

Weight Class (BMI) Seronegative Seropositive
Normal 26 71 <0.05
Obese 79 191 <0.05
Overweight 45 92 <0.05
Underweight 4 4 >0.05

BMI, body mass index; CAD, coronary artery disease; CCP, citrullinated peptide; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; G6PD, glucose-6-phosphate dehydrogenase; RF, rheumatoid factor.